Skip to main content

Peer Review reports

From: Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis

Original Submission
23 Nov 2017 Submitted Original manuscript
6 May 2018 Reviewed Reviewer Report - Eiki Ichihara
4 Jun 2018 Reviewed Reviewer Report - Katsuhiko Shimizu
1 Jul 2018 Author responded Author comments - Hironori Uruga
Resubmission - Version 2
1 Jul 2018 Submitted Manuscript version 2
7 Jul 2018 Reviewed Reviewer Report - Katsuhiko Shimizu
26 Jul 2018 Reviewed Reviewer Report - Eiki Ichihara
6 Aug 2018 Author responded Author comments - Hironori Uruga
Resubmission - Version 3
6 Aug 2018 Submitted Manuscript version 3
Publishing
13 Aug 2018 Editorially accepted
16 Aug 2018 Article published 10.1186/s12885-018-4743-5

You can find further information about peer review here.

Back to article page